Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation

South Africa, like many other developing countries, stands to benefit from novel diagnostics and drugs developed by pharmacogenomics guidance due to high prevalence of disease burden in the region. This includes both communicable (e.g., HIV/AIDS and tuberculosis) and non-communicable (e.g., diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Warnich, Louise, Drögemöller, Britt I, Pepper, Michael S, Dandara, Collet, Wright, Galen E.B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228231/
https://www.ncbi.nlm.nih.gov/pubmed/22563365
http://dx.doi.org/10.2174/187569211796957575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228231/
https://www.ncbi.nlm.nih.gov/pubmed/22563365
http://dx.doi.org/10.2174/187569211796957575

Ejemplares similares